FSH Testing in Perimenopause: Why One Test Isn’t Enough
FSH is having a quiet moment in longevity medicine — though most of us have not noticed yet. Follicle-stimulating hormone is still treated, in most practices, as a simple yes-or-no test: ordered once, or at most twice, to confirm menopause (or evaluate fertility), then set aside. But a growing body of research is reframing FSH as something more interesting: a longitudinal signal that may track how a woman’s bone, muscle, brain, and metabolism are aging. These are the very tissues we now think of as longevity organs. If that reframe holds, then the way most of us use FSH is leaving a great deal of information on the table.









